These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Wright JL, Porter MP, Li CI, Lange PH, Lin DW. Cancer; 2006 Aug 15; 107(4):721-8. PubMed ID: 16826584 [Abstract] [Full Text] [Related]
9. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG. J Urol; 2006 Aug 15; 176(2):493-8; discussion 498-9. PubMed ID: 16813876 [Abstract] [Full Text] [Related]
10. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Gopalan A, Sharp DS, Fine SW, Tickoo SK, Herr HW, Reuter VE, Olgac S. Am J Surg Pathol; 2009 May 15; 33(5):659-68. PubMed ID: 19252435 [Abstract] [Full Text] [Related]
12. [Clinicopathological features and prognosis of primary appendiceal adenocarcinoma]. Liang JW, Wang Z, Zhou ZX, Zhang XM, Hu JJ, Zhao P. Zhonghua Zhong Liu Za Zhi; 2012 Aug 15; 34(8):616-9. PubMed ID: 23158998 [Abstract] [Full Text] [Related]
14. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma. Chirieac LR, Swisher SG, Correa AM, Ajani JA, Komaki RR, Rashid A, Hamilton SR, Wu TT. Clin Cancer Res; 2005 Mar 15; 11(6):2229-36. PubMed ID: 15788671 [Abstract] [Full Text] [Related]